Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing substantial trading activity in Advanced Medical Solutions Group plc (AMS.L) ordinary shares.
The dealings were undertaken on 20th July 2026, with the formal disclosure published the following day, in compliance with Rule 8.5 of the Takeover Code.
Investec Bank plc acted in its capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity throughout the transactions.
The bank holds a significant advisory relationship with the company, serving as both Advisor and Joint Broker to Advanced Medical Solutions Group plc.
On the purchasing side, Investec acquired a total of 1,786,258 ordinary shares, with prices ranging from a low of 279.225 pence to a high of 280 pence per unit.
On the sales side, the bank disposed of 1,952,322 ordinary shares across the same price range of 279.225 to 280 pence per unit.
The volume of shares sold slightly exceeded purchases, reflecting active market-making and client-serving activity typical of a principal trader operating under recognised intermediary status.
No cash-settled derivative transactions, stock-settled derivative transactions, or other dealings such as subscriptions or conversions were reported as part of this disclosure.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that could serve as an inducement to deal or refrain from dealing in the relevant securities.
The bank similarly confirmed no agreements or understandings exist relating to voting rights or future acquisition and disposal of securities to which any derivative is referenced.
The contact named in the disclosure is Priyali Bhattacharjee, reachable by telephone for any related enquiries regarding the filing.
Public disclosures under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service, ensuring transparency during offer periods involving listed companies.
